MAYO CLINIC

🇺🇸United States

Country: 🇺🇸United States

Ownership: Subsidiary

Established: 1889-01-01

Employees: 10K

Market Cap: -

Website: http://www.mayoclinic.org

Clinical Trials

Mastery Learning Inguinal Hernia Repair

Not Applicable

Completed

Conditions: Inguinal Hernia

Interventions: Behavioral: Mastery Learning TEP Curriculum
Procedure: Current Practice

First Posted Date: 2010-03-12

Last Posted Date: 2016-10-28

Lead Sponsor: Mayo Clinic

Target Recruit Count: 50

Registration Number: NCT01085500

Locations: 🇺🇸
Mayo Clinic, Rochester, Minnesota, United States

The Role of the Fujinon Intelligent Chromo Endoscopy (FICE™) in Barrett's Esophagus

Completed

Conditions: Barrett's Esophagus

First Posted Date: 2010-03-10

Last Posted Date: 2021-12-15

Lead Sponsor: Mayo Clinic

Target Recruit Count: 50

Registration Number: NCT01084629

Locations: 🇺🇸
Mayo Clinic Rochester, Rochester, Minnesota, United States

Feasibility of Translumenal Endoscopic Omental Patch Closure of Perforated Viscus

Not Applicable

Completed

Conditions: Peptic Ulcer

Interventions: Device: Endoscopic Translumenal Omental Patch

First Posted Date: 2010-03-04

Last Posted Date: 2015-04-14

Lead Sponsor: Mayo Clinic

Target Recruit Count: 7

Registration Number: NCT01080326

Locations: 🇺🇸
Mayo Clinic, Rochester, Minnesota, United States

Pilot Pharmacokinetic Study of Daily Versus Monthly High-Dose Cholecalciferol Supplementation

Not Applicable

Completed

Conditions: Healthy Volunteers

Interventions: Dietary Supplement: Single High Dose Cholecalciferol
Dietary Supplement: Daily Dose Cholecalciferol

First Posted Date: 2010-03-03

Last Posted Date: 2012-11-20

Lead Sponsor: Mayo Clinic

Target Recruit Count: 40

Registration Number: NCT01079923

Locations: 🇺🇸
Mayo Clinic, Rochester, Minnesota, United States

Impact of a Decision Aid on Patient Decision Making in Emergency Department Chest Pain Patients

Not Applicable

Completed

Conditions: Acute Coronary Syndrome

Interventions: Other: Decision Aid

First Posted Date: 2010-02-26

Last Posted Date: 2015-05-06

Lead Sponsor: Mayo Clinic

Target Recruit Count: 204

Registration Number: NCT01077037

Locations: 🇺🇸
Mayo Clinic Rochester, Rochester, Minnesota, United States

Everolimus and Lenalidomide in Treating Patients With Relapsed or Refractory Non-Hodgkin or Hodgkin Lymphoma

Phase 1

Completed

Conditions: Hepatosplenic T-cell Lymphoma
Recurrent Mantle Cell Lymphoma
Splenic Marginal Zone Lymphoma
Anaplastic Large Cell Lymphoma
Peripheral T-cell Lymphoma
Recurrent Grade 2 Follicular Lymphoma
Waldenstrom Macroglobulinemia
Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue
Recurrent Adult Burkitt Lymphoma
Recurrent Mycosis Fungoides/Sezary Syndrome

Interventions: Drug: everolimus
Drug: lenalidomide
Other: laboratory biomarker analysis
Genetic: polymorphism analysis
Other: immunohistochemistry staining method
Genetic: microarray analysis
Genetic: fluorescence in situ hybridization

First Posted Date: 2010-02-25

Last Posted Date: 2020-10-22

Lead Sponsor: Mayo Clinic

Target Recruit Count: 58

Registration Number: NCT01075321

Locations: 🇺🇸
Mayo Clinic in Arizona, Scottsdale, Arizona, United States
🇺🇸
Mayo Clinic, Rochester, Minnesota, United States

A Pilot Study to Examine the Role of Nitazoxanide to Prevent Recurrence of Hepatitis C After Transplantation

Phase 1

Completed

Conditions: Hepatitis C Recurrence

Interventions: Drug: Nitazoxanide

First Posted Date: 2010-02-24

Last Posted Date: 2012-07-31

Lead Sponsor: Mayo Clinic

Target Recruit Count: 8

Registration Number: NCT01074203

Locations: 🇺🇸
Mayo Clinic College of Medicine, Rochester, Minnesota, United States

Bortezomib, Cyclophosphamide, and Dexamethasone in Treating Patients With Primary Systemic Light Chain Amyloidosis

Phase 2

Completed

Conditions: Primary Systemic Amyloidosis

Interventions: Drug: bortezomib
Drug: cyclophosphamide
Drug: dexamethasone

First Posted Date: 2010-02-22

Last Posted Date: 2014-04-02

Lead Sponsor: Mayo Clinic

Target Recruit Count: 2

Registration Number: NCT01072773

Locations: 🇺🇸
Mayo Clinic, Rochester, Minnesota, United States

Trendelenburg's Slide Prevention Study

Not Applicable

Completed

Conditions: Misadventure During Surgical Operation
Postoperative Complications

Interventions: Other: Egg crate foam mattress
Other: Gel pad

First Posted Date: 2010-02-15

Last Posted Date: 2012-05-15

Lead Sponsor: Mayo Clinic

Target Recruit Count: 60

Registration Number: NCT01068821

Locations: 🇺🇸
Mayo Clinic Florida, Jacksonville, Florida, United States

Lipoprotein-associated Phospholipase A2 (Lp-PLA2) Progenitor Cells and Coronary Atherosclerosis in Humans

Phase 3

Completed

Conditions: Endothelial Dysfunction

Interventions: Drug: darapladib
Drug: placebo

First Posted Date: 2010-02-11

Last Posted Date: 2017-04-18

Lead Sponsor: Mayo Clinic

Target Recruit Count: 70

Registration Number: NCT01067339

Locations: 🇺🇸
Mayo Clinic, Rochester, Minnesota, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy